Severity, reduction or cessation in nausea/vomiting 2. Number of episodes of emesis 3. Days of hospital admission 4. Pregnancy complications 5. Adverse fetal/neonatal outcomes · Pregnant women with hyperemesis gravidarum
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Length of hospital stay · Pregnant women with hyperemesis gravidarum
It is very uncertain whether ondansetron changes days of hospital admission compared with promethazine (very low certainty).
1 finding from 1 review
Severe nausea 17th day · Pregnant women with hyperemesis gravidarum
It is very uncertain whether corticosteroids changes severe nausea 17th day compared with promethazine (very low certainty).
1 finding from 1 review
Vomiting · Pregnant women with hyperemesis gravidarum
It is very uncertain whether corticosteroids changes episodes of vomiting 17th day compared with promethazine (very low certainty).
1 finding from 1 review
Intervention side effects: drowsiness 48hrs and 3‐10 days · Pregnant women with hyperemesis gravidarum
Corticosteroids showed no clear difference in intervention side effects: drowsiness 48hrs and 3‐10 days compared with promethazine (low certainty).
1 finding from 1 review
Duration of hospital admission (days) · Pregnant women with hyperemesis gravidarum
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Length of hospital stay · Pregnant women with hyperemesis gravidarum
1 finding from 1 review
Duration of hospital admission (days) · Pregnant women with hyperemesis gravidarum
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Duration of hospital admission (days) · Pregnant women with hyperemesis gravidarum
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mortality at day 30 · AKI
Intensive showed no clear difference in mortality at day 30 compared with less intensive continuous renal replacement therapy (CRRT) (low certainty).
1 finding from 1 review
Mortality after 30 days post‐randomisation · AKI
Intensive showed no clear difference in mortality after 30 days post‐randomisation compared with less intensive continuous renal replacement therapy (CRRT) (low certainty).
1 finding from 1 review
Sleep onset latency, next day; · Shift workers
1 finding from 1 review
Sleep efficiency · Shift workers
1 finding from 1 review
Total sleep time, next day ‐ main sleep time only; · Shift workers
1 finding from 1 review
Total sleep time, next day ‐ 24‐hr sleep time, including naps; · Shift workers
1 finding from 1 review
Sleep efficiency · Shift workers
1 finding from 1 review
Total sleep time, next day Diaries and actigraphy. Scale from: 120 to 600. · Shift workers
1 finding from 1 review
Ulcers completely healed · people with venous leg ulcers
It is very uncertain whether sulodexide + local treatment changes proportion of ulcers completely healed at 30 days compared with local treatment (very low certainty).
3 findings from 1 review
RR 1.91 [1, 3.66]
1 study · 114 participants
Very low
RR 1.65 [1.2, 2.28]
2 studies · 324 participants
Low
RR 1.6 [1.17, 2.2]
1 study · 230 participants
Low
All‐cause mortality in 30 days post operation · patients (15 years of age and older) undergoing non‐cardiac surgery under any type of anaesthesia
It is very uncertain whether nitroglycerin changes all‐cause mortality in 30 days post operation compared with no treatment (very low certainty).
1 finding from 1 review
All‐cause mortality in 30 days post operation · patients (15 years of age and older) undergoing non‐cardiac surgery under any type of anaesthesia
It is very uncertain whether nitroglycerin changes all‐cause mortality in 30 days post operation compared with placebo (very low certainty).
1 finding from 1 review